Endometrioma (Palliative Investigational Adjunct)
Palliative investigational adjunct for endometrioma-related chronic pelvic pain in patients declining or unable to undergo surgical/hormonal management.
Patient Summary
- Is this FDA-cleared for this use?
- Not FDA-cleared for endometrioma. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational and palliative-only, with no disease-modifying mechanism.
- What evidence exists?
- Tier C (investigational). No clinical study of leech therapy specific to endometrioma was found in our literature search. Small Russian studies in endometriosis in general (up to 82 women; not indexed in PubMed; randomization not described) reported less pain, but they give no results for endometrioma cysts, and we found no independent confirmation. Endometriomas are ovarian endometriotic cysts, a subtype of endometriosis, typically discovered on pelvic imaging. Evidence-based management includes hormonal suppression (combined oral contraceptives, progestins, GnRH agonists/antagonists, dienogest), laparoscopic cystectomy with biopsy (preferred over drainage for diagnosis and recurrence reduction), and addressing concurrent endometriosis. Premenopausal women considering surgery require AMH (anti-Mullerian hormone) assessment and discussion of impact on ovarian reserve.
- Main risks
- Bleeding from bite sites for 6 to 24 hours after detachment
- Bruising and tenderness over the lower abdomen for 5 to 10 days
- Local skin infection or Aeromonas infection
- Allergic reaction to leech saliva
- Cannot reach or affect the deep ovarian cyst from topical placement
- Delay of hormonal suppression or laparoscopic cystectomy, both of which are evidence-based
- Missed malignant transformation (rare but reported in endometriomas)
- Missed infertility evaluation if pregnancy is desired
- Who should not consider this
- Pregnant patients
- Patients with suspected malignant transformation
- Patients with acute endometrioma rupture or torsion (surgical emergency)
- Patients in active infertility evaluation considering surgery
- Patients within 12 weeks of abdominal or pelvic surgery
- Patients on anticoagulants or with anemia
- What to ask your clinician
- Has endometrioma been confirmed by ultrasound or MRI, with malignancy concern addressed?
- Have I been offered hormonal suppression (combined OC, progestins, dienogest, GnRH agonist/antagonist)?
- Have I been offered laparoscopic cystectomy, and what does AMH testing show about my ovarian reserve?
- If I want to preserve fertility, have I been referred to reproductive endocrinology?
- Where exactly will the leech be placed, and why is the abdominal wall expected to help a deep ovarian cyst?
- Has it been clearly explained that this is palliative-only, not disease-modifying?
- When to seek urgent care
- Sudden severe one-sided abdominal or pelvic pain (rule out rupture or torsion)
- Heavy or unusual vaginal bleeding
- Fever above 38.0 C / 100.4 F or chills
- Persistent vomiting or signs of acute abdomen
- Bleeding from a bite site lasting more than 24 hours
- Spreading redness, warmth, or pus at any bite site
What this does NOT mean
- It has not been shown to shrink or treat endometriomas; the only supporting reports are small Russian studies in endometriosis in general, with no endometrioma-specific results.
- It does not replace hormonal suppression or laparoscopic cystectomy, both of which have evidence support.
- It has not been shown to improve fertility; the pregnancy rates reported in small Russian studies (for example 8 of 35 infertile women versus 2 of 20 on hormonal therapy) come from small comparisons without described randomization and have not been confirmed independently.
- It is palliative only and only when standard therapy is declined or unavailable.
Safety cross-references
Clinical Profile
- Category
- Gynecologic
- ICD-10
- N80.1, N80.10
- Safety tier
- Medium
Evidence Summary
Endometriomas are ovarian endometriotic cysts, a subtype of endometriosis, typically discovered on pelvic imaging. Evidence-based management includes hormonal suppression (combined oral contraceptives, progestins, GnRH agonists/antagonists, dienogest), laparoscopic cystectomy with biopsy (preserved over drainage for diagnosis and recurrence reduction), and addressing concurrent endometriosis. Premenopausal women considering surgery require AMH assessment and discussion of ovarian reserve impact. No clinical study of leech therapy specific to endometrioma was identified in PubMed, Europe PMC, Crossref, ClinicalTrials.gov, or the Baskova and Isakhanyan (2004) monograph. The nearest evidence concerns genital endometriosis in general, all from Russia and not indexed in PubMed: a 2004 candidate dissertation from Perm (Lomaeva; 82 women given leeches compared with 30 given hormonal therapy, randomization not described, ovarian endometriosis present in a minority) and two series of 40 and 41 women described without a comparison group in the monograph (Zhivoglyad and Nikonov 1998; Startseva 2001). They report less pain and improvement on ultrasound, but none gives endometrioma-specific results and no independent replication was identified. A disease-modifying effect on endometriomas has not been shown.
What the books describe
Below is a summary of what books on hirudotherapy say about this condition. These are the authors’ observations, not a proven effect and not a promise of results. Hirudotherapy has contraindications; the decision is made by a physician.
- Baskova and Isakhanyan do not write about endometrioma as a separate condition: the book describes endometriosis as a whole, and it is not clear from the text whether the patients included women with ovarian cysts[B1].
- For endometriosis as a whole they give two observations: Zhivoglyad and Nikonov (1998) — 40 patients, in 24 of whom ultrasound examination showed no residual symptoms of endometriosis; Startseva et al. (2001) — 41 women, in 25 of whom, according to their report, the size of the endometriosis foci decreased[B1].
- These descriptions do not mention a comparison group and give no separate results for ovarian cysts[B1].
- Among the contraindications Baskova and Isakhanyan name hemophilia, hemorrhagic diatheses, anemias and concurrent use of anticoagulants[B1].
- On pregnancy, Baskova and Isakhanyan write that the question of prescribing hirudotherapy remains open; Michalsen et al. (the chapter on contraindications by Flecken and Michalsen) regard treatment involving blood loss as generally contraindicated during pregnancy[B1][B3].
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)
Contraindications
- Hemophilia or another bleeding disorder
- Taking anticoagulants (blood thinners such as warfarin or heparin)
- Anemia or suppressed blood formation
- Low blood pressure, shock, collapse or fainting
- Severe wasting (cachexia)
- Intolerance of leeches or a history of severe allergic reactions
- Pregnancy
- Stomach or duodenal ulcer, erosive gastritis
- Acute infectious disease or high fever
- Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
- Drinking alcohol at the time of treatment
- No consent from the patient
- Pregnancy
- Suspected malignant transformation (rare but reported)
- Acute endometrioma rupture or torsion
- Concurrent infertility evaluation actively considering surgery
- Recent abdominal surgery
Related Conditions
Endometriosis-Related Pelvic Pain
Investigational adjunctive use for chronic endometriosis-related pelvic pain; very limited evidence. Not a substitute for hormonal or surgical management.
Primary Dysmenorrhea
Investigational for primary dysmenorrhea; one small randomized trial of leeches plus cupping versus an oral contraceptive pill reported lower pain scores.
Chronic Pelvic Pain Syndrome (Non-Specific)
Investigational for non-specific chronic pelvic pain; the only clinical report located is an uncontrolled 60-woman series in which leeches were one part of multimodal care.
Lactational Mastitis (Non-Suppurative)
Investigational adjunctive use proposed for non-suppurative lactational mastitis; no clinical study of leech therapy was identified.
References
- [B1]
Баскова И.П., Исаханян Г.С. Гирудотерапия. Наука и практика [Hirudotherapy: Science and Practice]
Monograph in Russian, 506 pp., ISBN 5-89527-058-1. Chapter 15: sensation at the bite, length of the session; secretion kininases and pain.
- [B3]
Michalsen A., Roth M., Dobos G. Medicinal Leech Therapy
ISBN 978-3-13-143581-1 / 978-1-58890-563-5. Chapter 9, p. 107: perceptions of the bite — a local dragging pain lasting around one to five minutes.
The information on this page is based on the hirudotherapy books listed under References and reflects the experience their authors describe. Sensations and results differ from person to person. This information is not medical advice, a diagnosis or a prescription, and it does not replace an examination by a physician. Do not stop or change any prescribed treatment without your physician. Hirudotherapy has contraindications.